[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
February 13, 2013

Community Research Partnerships: Underappreciated Challenges, Unrealized Opportunities

Author Affiliations

Author Affiliations: Counsel for Human Research, The Johns Hopkins Hospital and Health System, Baltimore, Maryland (Dr Kulynych); and KGH Advisors LLC, Hingham, Massachusetts (Ms Heffernan).

JAMA. 2013;309(6):555-556. doi:10.1001/jama.2012.108937

Thousands of physicians, predominantly in primary care and oncology, participate in community research networks sponsored by federal entities, industry, and academia.1,2 These numbers, however, are insufficient to achieve the goals of translational research or to realize the potential of ambitious new proposals to fully integrate research and clinical care.3 As attorneys representing academic medical centers (AMCs) that are building research networks, we know that physicians value participation but are deterred by the uncompensated time, uncertain liability, and regulatory complexity of research. Existing network models provide community physicians access to clinical trials but often little help managing research risk or building compliance infrastructure.